Operationalizing a Decision‐Making for Adverse Event Reporting Toolkit (DART) for Aging and Serious Illness Research.

Introduction: Monitoring adverse events (AEs) assures patient safety in clinical trials. Studies involving seriously ill and older adults can have a high volume of AEs related to underlying courses of illness rather than study procedures. Trials not regulated by the Food and Drug Administration (FDA...

Descripción completa

Detalles Bibliográficos

Publicado en:	Journal of the American Geriatrics Society Vol. 74; no. 6; pp. 1692 - 1698
Autores principales:	Lubetsky, Sara, Woodrell, Christopher, Schiller, Gabrielle, Bowman, Brynn, Heitner, Rachael, Morrison, R. Sean, Siu, Albert L., Kitzman, Dalane, Baim‐Lance, Abigail
Formato:	Artículo
Publicado:	Wiley-Blackwell Jun2026
Materias:	United States. Food & Drug Administration Medical care research Drug side effects Patient safety Government agencies Professional associations Decision making Aging Medical research Research ethics Public health laws Research funding Severity of illness index
Acceso en línea:	Ver este registro en EBSCOhost